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Research Updates

Research highlights
Homoeopathy – Most Frequently Used Treatment
Option in Small Animal Medicine
Title: Application of veterinary naturopathy and complementary
medicine in small animal medicine – A survey among German
veterinary practitioners
Authors: Ines Stanossek, Axel Wehrend
Journal: PLoS One, DOI: 10.1371/journal.pone.0264022
Summary: Recent studies have shown a rapid increasing
interest of veterinary naturopathy along with complementary
medicine. However, to describe this state in Germany, the data
are still lacking. The present study aimed at addressing the issue
by identifying the present treatment indications, modalities,
information pathways and existing qualifications. The study
records the advantages and disadvantages of the various modes
of treatments as experienced by the veterinarians through
demographic influence. A cross-sectional survey was conducted
using a standardised questionnaire. From 1087 questionnaires,
870 were evaluated. From the literature reviews, the most used
treatments were as follows: Homoeopathy, traditional Chinese
medicine, phytotherapy, manual treatments, biophysical
treatments, Bach flower remedies, homotoxicology, neural
therapy, organotherapy and hirudotherapy. Mann–Whitney
U-test and the exact Fisher’s test were used to calculate the
impact observed through demographic data. Homoeopathy
emerged to be the most frequently used treatment option high
potential.
Comments: Not only in human population but also in
veterinarians, homoeopathy has proved to be beneficial and
remains the preferred choice over other modes of treatment
worldwide.

Anti-leishmanial Efficacy of LdAPN 30C – A
Homoeopathic Nosode
Title: Evidence for Reversal of Immunosuppression by
Homoeopathic Medicine to a Predominant Th1-type Immune
Response in BALB/c Mice Infected with Leishmania
donovani.
Authors: Jyoti Joshi, Chetna Bandral, Raj Kumar Manchanda,
Anil Khurana, Debadatta Nayak, Sukhbir Kaur
Journal: Homoeopathy, DOI: 10.1055/s-0041-1727170
Summary: The study highlights immunomodulatory potential
and the anti-leishmanial activity of a proposed homoeopathic
nosode, ‘LdAPN 30C’ (Leishmania donovani promastigote and
amastigote Nosode), in the experimental VL. The nosode was
prepared from pure, axenic culture of the Leishmania donovani

and its further screening was done in both, in vitro and in vivo,
to analyse its anti-leishmanial potential.
In this study, the growth inhibition percentage was assessed
against the promastigotes of L. donovani treated with different
dilutions of LdAPN 30C. It was also observed that the
nosode killed about 93% parasites at 256 µL/mL dilution,
showing remarkable anti-leishmanial potential. The nosodes,
LdAPN 30C, were successfully efficacious in controlling the
experimental VL in mice, increased levels of IL-17, IFN-γ
and NO, shift was seen in the immune response, from nonprotective Th2 to protective Th1 type and remarkable potential
against VL.
Comments: Insufficiency of reliable drugs, absence of human
vaccine and the spread of this disease to non-endemic regions
highlight the requirement of better treatment options for such
conditions. Homoeopathic nosodes can be a beneficial option
to intercept conditions like leishmaniasis.

Vitamin D Supplementation for COVID-19
Title: Short-term, high-dose Vitamin D supplementation for
COVID-19 disease: A randomised, placebo-controlled and
study (SHADE study)
Authors: Ashu Rastogi, Anil Bhansali, Niranjan Khare, Vikas
Suri, Narayana Yaddanapudi, Naresh Sachdeva, G D Puri,
Pankaj Malhotra
Journal: Postgraduate medical journal, doi:10.1136/
postgradmedj-2020-139065
Summary: This randomised placebo-controlled study was
conducted to explore the role of Vitamin D intervention.
Although Vitamin D is known for its immunomodulatory
role, still the therapeutic effect of Vitamin D supplementation
in people infected with SARS-CoV-2 remains unknown.
Asymptomatic or patients with mild symptoms with
SARS-CoV-2 RNA positive with deficient Vitamin D (25(OH)
D<20 ng/ml) were included in the study. The participants
received cholecalciferol 60,000 IU for 7 days along with the
therapeutic target of participants were randomised to receive
daily 60,000 IU of cholecalciferol (oral nano-liquid droplets)
for 7 days with 25(OH)D>50 ng/ml (intervention group) and
placebo (control group). 25(OH)D levels were estimated
at the 7th day whereas cholecalciferol supplementation was
continued for patients with 25(OH)D <50 ng/ml in the
intervention group.
In this study, 40 SARS-CoV-2 RNA-positive individuals
were randomised. Out of that, 16 were taken to the
intervention group and 24 were recruited in the control
group. Baseline serum 25(OH)D was 8.6 (7.1–13.1) and
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9.54 (8.1–12.5) ng/ml (P = 0.730), in the intervention and
control group, respectively. Ten out of 16 patients could
achieve 25(OH)D>50 ng/ml by day-7 and another two by
day-14 [day-14, 25(OH)D levels 51.7 (48.9–59.5) ng/ml
and 15.2 (12.7–19.5) ng/ml (P < 0.001)] in the intervention
and control group, respectively. Ten (62.5%) participants
in the intervention group and 5 (20.8%) participants in
the control arm (P < 0.018) became SARS-CoV-2 RNA
negative. It was seen that fibrinogen levels significantly
decreased with cholecalciferol supplementation (intergroup
difference 0.70 ng/ml; P = 0.007) unlike other inflammatory
biomarkers.

Chimaphila Umbellata on Human Breast Cancer
Cells

Comments: Cholecalciferol supplementation in patients
infected with SARS-CoV-2 showed a remarkable improvement
by turning SARS-CoV-2 RNA negative along with a significant
decrease in the inflammatory markers as well.

Summary: For homoeopathic preparation of Chimaphila
umbellata, the roots and leaves of the plant are used. This
study interrogates the apoptotic and antiproliferative
effects of the Chimaphila umbellata mother tincture on
the cell lines of human breast cancer. For the evaluation
of the time-dependent and dose-dependent toxicity of the
Chimaphila extract in HEK293 and MCF-7 cells, MTT
assay was used. Wound healing and clonogenic assays
were used for the evaluation of antiproliferative effect,
whereas to study the antiangiogenic drug activity chick
chorioallantoic membrane assay. For analysing the mode
of cell death, PI staining and Annexin V assay by flow
cytometry were used. In addition to this, expression patterns
of the associated genes were assessed using the immunoblot
analysis. CU extracts produced antiproliferative effect in the
MCF-7 cells, further inhibiting their migration and growth.
Significant antiangiogenic ability was also demonstrated
from the extract, which limited growth of new blood
vessels and also development in the chick embryos. The
extract promotes the caspase-independent necroptosis with
an involvement of RIP1/RIP3 kinases along with MLKL
proteins.

Individualised Homoeopathic Medicines in Plantar
Fasciitis
Title: Efficacy of individualised homoeopathic medicines
in plantar fasciitis: A double-blind, randomised, placebocontrolled clinical trial
Authors: Sana Shahid , Shubhamoy Ghosh, Ardhendu Shekhar
Chakraborty, Shukdeb Maiti, Satarupa Sadhukhan, Munmun
Koley, Subhranil Saha
Journal: Homoeopathy, DOI: 10.1055/s-0041-1731383
Summary: A randomised double-blind, placebo-controlled
trial was conducted at the OPDs of Mahesh Bhattacharyya
Homoeopathic Medical College and Hospital, West Bengal,
India. For the outcome measure, the Foot Function Index
(FFI) questionnaire was administered at the baseline and
every month up to 3 months. The group differences (unpaired
t-tests) and the effect sizes (Cohen’s d) were calculated using
intention-to-treat sample. At every time point, difference
among the groups for total FFI% score favoured the IHMs
against the placebo, at the 1st month (mean difference, −10.0;
95% confidence interval [CI], −15.7−4.2; P = 0.001; d = 0.8);
at month 2 (mean difference, −14.3; 95% CI, −20.4–8.2;
P < 0.001; d = 1.1) and at the 3rd month (mean difference,
−23.3; 95% CI, −30.5–16.2; P < 0.001; d = 1.5). Significant
results were observed at 3 FFI sub-scales (pain%, disability%
and activity limitation %). The frequently prescribed
homoeopathic medicines were Natrum muriaticum (n = 14;
18.7%), Rhus toxicodendron and Ruta graveolens (n = 11
each; 14.7%) medicines. IHMs acted comparably better than
the verum in the treatment of PF.
Comments: Use of standardised scales and appropriate
comprehensive parameters helps in validating the study to
a greater level. Similar studies with a larger sample size
must be conducted to support the efficacy of individualised
homoeopathic medicine(s).
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Title: Chimaphila umbellata extract exerts antiproliferative
effect on human breast cancer cells through RIP1K/RIP3Kmediated necroptosis
Authors: Neeladrisingha Das, Subhashish Samantaray,
Chandrachur, GhoshKomal Kushwaha Debabrata Sircar,
Partha Roy
Journal: Phytomedicine Plus, https://doi.org/10.1016/j.
phyplu.2021.100159

Comments: As per the homoeopathic literature, Chimaphila
umbellata exhibits great potential in preventing breast cancer.
This study supports this knowledge and also warrants further
in vivo investigations.

Antinociceptive Activity of Bacopa Monnieri
Article Title: Antinociceptive activity of standardized
extract of Bacopa monnieri in different pain models of
zebrafish
Journal: Journal of Ethnopharmacology, doi.org/10.1016/j.
jep.2021.114546
Authors: Mahima Sharma, Pankaj Kumar Gupta, Pankaj
Gupta, Debapriya Garabadu
Summary: Bacopa monnieri which is commonly known
as Brahmi has been traditionally used as a neuroprotective
medicine. In this in vivo study, methanolic extract of Bacopa
monnieri was standardised to a chromatographic method
called bacoside. Later, the “antinocicepetive” potential of
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the methanolic extract of Bacopa monnieri L. (0.75, 1.25,
2.5 and 5.0 mg/ml) was evaluated using an adult zebrafish,
as a pain model. Standardised Bacopa monnieri extract
exhibited antioxidant effect through the radical quenching
activity. The extract of Bacopa monnieri at 1.25 mg/ml
significantly lowered the nociceptive effect produced by
various harmful agents like acetic acid. However, when
compared to control and sham group, Bacopa extract at
2.5 mg/ml showed significant antinociceptive activity
against various agents such as formalin, capsaicin,
glutamate and cinnamaldehyde.
Comments: This experimental study exhibits the
antinoiciceptive activity of the methanolic extract of Bacopa
monnieri, therefore, suggesting its therapeutic potential in the
management of neuropathic pain.
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